Literature DB >> 12228172

Leflunomide decreases joint erosions and induces reparative changes in a patient with psoriatic arthritis.

M Cuchacovich, L Soto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12228172      PMCID： PMC1753922          DOI： 10.1136/ard.61.10.942

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  4 in total

Review 1.  Treatment advances in psoriatic arthritis.

Authors:  Eric M Ruderman
Journal:  Curr Rheumatol Rep       Date:  2005-08       Impact factor: 4.592

2.  Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitis.

Authors:  J C van Denderen; M van der Paardt; M T Nurmohamed; Y M M A de Ryck; B A C Dijkmans; I E van der Horst-Bruinsma
Journal:  Ann Rheum Dis       Date:  2005-05-18       Impact factor: 19.103

Review 3.  Traditional and newer therapeutic options for psoriatic arthritis: an evidence-based review.

Authors:  Dafna D Gladman
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 4.  [Psoriatic arthritis].

Authors:  Edmund Cauza; Attila Dunky
Journal:  Wien Med Wochenschr       Date:  2006-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.